Georgian invests in Welltok's $75 mln Series E2 round

U.S. consumer health enterprise software company Welltok Inc has secured US$75 million in a Series E2 financing. The round saw participation from both new and existing investors, including Canadian growth equity firm Georgian Partners. Denver, Colorado-based Welltok, founded in 2009, said the funds raised will be used for product development, expansion in new market segments, and integration of acquired assets and capabilities. Last October, the company bought Tea Leaves Health, an analytics and marketing platform used by hospital systems.

CanadaNorth AmericaBriefs